Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference.
Chronic risperidone administration leads to greater amphetamine-induced conditioned place preference.
复制标题
慢性利培酮给药导致更大的安非他明诱导的条件性位置偏爱。
DOI:
10.1016/j.neuropharm.2020.108276
复制
发表时间:
2020-11-15
影响因子:
4.7
通讯作者:
Pauly JR
中科院分区:
文献类型:
--
作者:
Bardgett ME;Downnen T;Crane C;Baltes Thompson EC;Muncie B;Steffen SA;Yates JR;Pauly JR
Risperidone is an atypical antipsychotic drug used increasingly in children to manage symptoms of ADHD and conduct disorder. In rats, developmental risperidone administration is accompanied by increased locomotor activity during adulthood, as well as heightened sensitivity to the locomotor stimulating effects of amphetamine. This study compared sensitivity to the rewarding effects of amphetamine, as measured by conditioned place preference (CPP), between groups of rats administered chronic risperidone (3.0 mg/kg, s.c.) during development (postnatal days 14-42) or adulthood (postnatal days 77-105). Locomotor activity in a novel test cage and amphetamine-induced CPP were measured beginning three and four weeks, respectively, after the final risperidone injection. Female rats administered risperidone early in life were more active than any other group tested. Previous risperidone administration enhanced amphetamine CPP regardless of sex, and this effect appeared more prominent in the developmentally treated group. The density of forebrain dopamine transporters, a primary target of amphetamine, was also quantified in rats administered risperidone early in life and found to be reduced in the medial anterior, posterior, and ventral caudate nucleus. These results suggest that chronic risperidone treatment modifies later locomotor activity and sensitivity to the reinforcing effects of amphetamine, perhaps via a mechanism related to decreased forebrain dopamine transporter density.
登录
查看更多内容
影响因子:
5.6
作者:
Choi, Yong Kee;Moran-Gates, Taylor;Gardner, Matthew P.;Tarazi, Frank I.
通讯作者:
Tarazi, Frank I.
DOI:
10.1016/j.pbb.2015.02.019
发表时间:
2015-05
期刊:
Pharmacology, biochemistry, and behavior
影响因子:
--
作者:
Lenoir M;Starosciak AK;Ledon J;Booth C;Zakharova E;Wade D;Vignoli B;Izenwasser S
通讯作者:
Izenwasser S
影响因子:
2.7
作者:
Bardgett,Mark E.;Crane,Casey;Downnen,Tyler
通讯作者:
Downnen,Tyler
影响因子:
2.3
作者:
Bardgett, Mark E.;Franks-Henry, Julie M.;Griffith, Molly S.
通讯作者:
Griffith, Molly S.
影响因子:
6.6
作者:
Bedard, Anne-Marie;Maheux, Jerome;Samaha, Anne-Noel
通讯作者:
Samaha, Anne-Noel